Traynor Capital Management’s Merck MRK Stock Holding History

Traynor Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81M	Sell	21,894 -621	-3%	-$72.7K	0.13%	86
2026 Q1	$2.66M	Sell	22,515 -26	-0.1%	-$3K	0.16%	78
2025 Q4	$2.37M	Sell	22,541 -242	-1%	-$22.7K	0.13%	82
2025 Q3	$1.91M	Buy	22,783 +1,774	+8%	+$146K	0.11%	81
2025 Q2	$1.72M	Sell	21,009 -4,107	-16%	-$326K	0.12%	73
2025 Q1	$2.25M	Sell	25,116 -2,270	-8%	-$212K	0.19%	71
2024 Q4	$2.72M	Buy	27,386 +13,976	+104%	+$1.44M	0.18%	69
2024 Q3	$1.52M	Buy	13,410 +2,314	+21%	+$275K	0.09%	87
2024 Q2	$1.37M	Buy	11,096 +626	+6%	+$80.6K	0.1%	81
2024 Q1	$1.38M	Buy	10,470 +207	+2%	+$25.5K	0.12%	85
2023 Q4	$1.12M	Sell	10,263 -282	-3%	-$29.3K	0.11%	85
2023 Q3	$1.09M	Buy	10,545 +76	+0.7%	+$8.19K	0.14%	80
2023 Q2	$1.21M	Buy	10,469 +126	+1%	+$14.3K	0.15%	76
2023 Q1	$1.1M	Buy	10,343 +104	+1%	+$11.2K	0.16%	76
2022 Q4	$1.14M	Buy	10,239 +15	+0.1%	+$1.53K	0.16%	76
2022 Q3	$880K	Buy	10,224 +170	+2%	+$15.2K	0.16%	73
2022 Q2	$916K	Buy	10,054 +327	+3%	+$29K	0.16%	71
2022 Q1	$798K	Buy	9,727 +194	+2%	+$15.3K	0.1%	89
2021 Q4	$730K	Buy	9,533 +1,884	+25%	+$150K	0.09%	106
2021 Q3	$574K	Sell	7,649 -742	-9%	-$56.4K	0.08%	110
2021 Q2	$659K	Sell	8,391 -529	-6%	-$39.3K	0.09%	99
2021 Q1	$656K	Sell	8,920 -273	-3%	-$20.1K	0.11%	94
2020 Q4	$717K	Buy	9,193 +892	+11%	+$68.2K	0.13%	80
2020 Q3	$632K	Buy	8,301 +843	+11%	+$66K	0.14%	84
2020 Q2	$550K	Buy	7,458 +8	+0.1%	+$602	0.13%	85
2020 Q1	$546K	Sell	7,450 -44	-0.6%	-$3.46K	0.19%	67
2019 Q4	$650K	Sell	7,494 -616	-8%	-$50.6K	0.17%	90
2019 Q3	$651K	Buy	8,110 +460	+6%	+$36.9K	0.2%	85
2019 Q2	$618K	Sell	7,650 -2,820	-27%	-$216K	0.2%	85
2019 Q1	$830K	Buy	10,470 +90	+0.9%	+$6.73K	0.28%	66
2018 Q4	$756K	Buy	10,380 +163	+2%	+$11.5K	0.32%	57
2018 Q3	$691K	Buy	10,217 +648	+7%	+$41.3K	0.22%	72
2018 Q2	$552K	Buy	9,569 +7	+0.1%	+$395	0.2%	80
2018 Q1	$497K	Sell	9,562 -102	-1%	-$5.51K	0.2%	80
2017 Q4	$518K	Sell	9,664 -1,028	-10%	-$57K	0.22%	82
2017 Q3	$655K	Buy	10,692 +52	+0.5%	+$3.15K	0.31%	68
2017 Q2	$646K	Buy	10,640 +743	+8%	+$45.2K	0.32%	65
2017 Q1	$604K	Buy	9,897 +264	+3%	+$16K	0.34%	65
2016 Q4	$564K	Buy	9,633 +186	+2%	+$10.9K	0.37%	59
2016 Q3	$557K	Sell	9,447 -110	-1%	-$6.43K	0.39%	56
2016 Q2	$528K	Sell	9,557 -567	-6%	-$30.2K	0.41%	55
2016 Q1	$511K	Sell	10,124 -836	-8%	-$40.9K	0.41%	54
2015 Q4	$552K	Buy	10,960 +3,193	+41%	+$161K	0.4%	55
2015 Q3	$366K	Sell	7,767 -940	-11%	-$49.9K	0.32%	69
2015 Q2	$472K	Buy	+8,707	New	+$488K	0.39%	57

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Traynor Capital Management's MRK Position: Q2 2026 in Review

Traynor Capital Management reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $72.7K and leaving 21,894 shares worth $2.81M. The position accounts for 0.13% of the portfolio, ranked #86.

Traynor Capital Management first reported a position in MRK in Q2 2015 and has held it in 45 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Traynor Capital Management held 21,894 shares of Merck worth $2.81M as of Q2 2026.
Traynor Capital Management sold 621 Merck shares in Q2 2026, an estimated $72.7K.
Merck made up 0.13% of Traynor Capital Management's portfolio in Q2 2026, its #86 holding.
Traynor Capital Management first reported a position in Merck in Q2 2015 and has held it in 45 quarters since.
1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.